DeepMed Research

TEHRAN UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1934-01-01

Employees: 1K

Market Cap: -

Website: http://www.tums.ac.ir

Clinical Trials

Assessing the Effects of Alfacalcidol Intake on Expression of Involed Gene in Metabolism in Obese Subjects

Not Applicable

Conditions: Obesity

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Alfacalcidol

First Posted Date: 2012-12-19

Last Posted Date: 2012-12-27

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 94

Registration Number: NCT01752244

Locations: 🇮🇷
TehranUMS, Tehran, Iran, Islamic Republic of

Comparison of Propofol-fentanyl and Midazolam-fentanyl for Conscious Sedation

Phase 4

Conditions: Emergencies

Interventions: Drug: Midazolam
Drug: Propofol
Drug: Fentanyl

First Posted Date: 2012-12-13

Last Posted Date: 2012-12-13

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT01749579

Locations: 🇮🇷
Imam Khomeini Hospital, Tehran, Iran, Islamic Republic of

Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic

Phase 3

Conditions: Pain
Renal Colic

Interventions: Drug: Desmopressin intranasal spray
Drug: Placebo intranasal spray
Drug: Indomethacin suppository

First Posted Date: 2012-12-05

Last Posted Date: 2012-12-05

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 88

Registration Number: NCT01742689

Locations: 🇮🇷
Imam Khomeini General Hospital, Tehran, Iran, Islamic Republic of
🇮🇷
Shariati Hospital, Tehran, Iran, Islamic Republic of

Effect of N-acetylcystein in Myocardial Infarction

Phase 3

Conditions: Acute Myocardial Infarction

Interventions: Drug: N-acetylcystein

First Posted Date: 2012-12-04

Last Posted Date: 2012-12-04

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 100

Registration Number: NCT01741207

Locations: 🇮🇷
Teran Heart Center, Tehran, Iran, Islamic Republic of

Efficacy of Antiviral Medications in Controlling Vertigo Attacks of Patients With Meniere's Disease

Phase 2

Conditions: Meniere's Disease

Interventions: Drug: Acyclovir
Drug: Placebo

First Posted Date: 2012-11-20

Last Posted Date: 2012-11-20

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 80

Registration Number: NCT01729767

Locations: 🇮🇷
Amiralam Hospital, Tehran, Iran, Islamic Republic of

Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease

Phase 2

Completed

Conditions: Non-alcoholic Fatty Liver Disease

Interventions: Drug: H.pylori eradication

First Posted Date: 2012-10-23

Last Posted Date: 2018-06-28

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 40

Registration Number: NCT01712711

Locations: 🇮🇷
Gastroenterology clinic, Sina Hospital, Tehran, Iran, Islamic Republic of

Impact of Vitamin A on RAR Gene Expression in Multiple Sclerosis

Phase 4

Conditions: Relapsing Remitting Multiple Sclerosis

Interventions: Drug: placebo

First Posted Date: 2012-10-12

Last Posted Date: 2012-10-12

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 20

Registration Number: NCT01705457

Locations: 🇮🇷
Tehran University of Medical Sciences,, Tehran, Iran, Islamic Republic of

Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure

Phase 2

Completed

Conditions: Type 2 Diabetes Mellitus
Diabetic Nephropathy
Essential Hypertension

Interventions: Drug: spironolacone 25 mg tablets added to losartan

First Posted Date: 2012-08-17

Last Posted Date: 2012-08-28

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 136

Registration Number: NCT01667614

Locations: 🇮🇷
Tehran University of Medical Sciences, Vali-asr hospital, Endocrinology and Metabolism Research Center, Tehran, Iran, Islamic Republic of

Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control

Phase 4

Completed

Conditions: Paroxysmal Supraventricular Tachycardia

Interventions: Drug: Verapamil

First Posted Date: 2012-08-01

Last Posted Date: 2012-11-14

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 90

Registration Number: NCT01655316

Rate Control in Atrial Fibrillation

Phase 4

Completed

Conditions: Rapid Ventricular Response Atrial Fibrillation

Interventions: Drug: Metoprolol
Drug: Verapamil
Drug: Propranolol
Drug: Diltiazem

First Posted Date: 2012-08-01

Last Posted Date: 2012-08-01

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 90

Registration Number: NCT01655303

Locations: 🇮🇷
Rasoul-e-Akram Hospital, Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy